Fig. 5From: A Design of Experiment (DoE) based approach for development and optimization of nanosuspensions of telmisartan, a BCS class II antihypertensive drugContour plot showing the effect of HPMC E15 and stirring speed on particle size and cumulative percentage drug releaseBack to article page